🇺🇸 FDA
Patent

US 6071497

Microparticles for lung delivery comprising diketopiperazine

expired A61KA61K9/0073A61K9/0075

Quick answer

US patent 6071497 (Microparticles for lung delivery comprising diketopiperazine) held by Pharmaceutical Discovery Corporation expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Pharmaceutical Discovery Corporation
Grant date
Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K9/0073, A61K9/0075, A61K9/1617, A61K9/5146